The KOASTAL-1 study enrolled 383 adult patients with MDD. Navacaprant was shown to be safe and generally well-tolerated with ...

Chime Biologics, a global CDMO, and Mabgeek, a clinical-stage innovative antibody drug development biotech, have successfully ...

Innovent Biologics Inc., a biopharmaceutical company that develops, manufactures and commercializes medicines, has entered a ...

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, has appointed Lori ...

Veeda Group has unveiled a new logo and brand identity— Veeda Lifesciences —reflecting the brand’s evolution from a ...

Sangamo plans to explore all options to commercialize the Hemophilia A asset.

Averaging up to 20% of weight loss, adults taking Zepbound had 25 fewer breathing interruptions each hour as they slept.

Adicet Bio Inc., a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies ...

Becomes the first subcutaneously administered PD-1 inhibitor.

The expanded facility will focus on manufacturing injectable medicines, device assembly and packaging for medicines across ...

Charles Sternberg is a driven writer and editor with a well developed passion for creativity and innovation seeking to ...

LGM Pharma’s chief executive talks industry trends and the company’s continued growth as a provider of tailored API and CDMO services. Contract Pharma is the premier media outlet linking contract ...